Diabetes Type 2

 
Interview: Delay in Second-line T2D Treatment Among Younger US Veterans Sparks Investigator Concern
May 10, 2022

HbA1c levels over time were found higher at initiation of second-line treatment in veterans aged 55 years and younger, a trend unsettling to a new study's lead author.

Latest Advances in CGM Technology: A 5-question Quiz
May 06, 2022

SAMPLE: What was the first FDA-approved CGM system to include a fully implantable sensor to detect glucose?

Study Author Reviews Results: Trends in Time to Initiation of Second-line T2D Treatment
May 05, 2022

Initiation of second-line type 2 diabetes treatment is lagging while A1c at the time it is introduced is climbing. The author of a new study highlights his findings on clinical inertia.

SGLT-2 Inhibitor and GLP-1 Receptor Agonist Prescribing Trends 2015-2020
May 04, 2022

PCPs and internists accounted nationally for 57% of SGLT2i and 52% of GLP1RA prescriptions in 2020, more than any other specialty, according to new research.

Intranasal Insulin Could Help Slow Age-related Cognitive Decline, Suggests a New Study
May 03, 2022

Treatment with intranasal insulin improved executive function and verbal memory, as well as other measures, in participants with and without type 2 diabetes.

Novel Once-Weekly Insulin Icodec Found Superior vs Insulin Degludec in Reducing HbA1c in Type 2 Diabetes
April 29, 2022

The ONWARDS 2 trial achieved its primary endpoint of demonstrating non-inferiority in reducing HbA1c at week 26 with insulin icodec vs insulin degludec.

Newly Developed Polygenic Risk Scores May Assist Decision-making in Primary Care
April 21, 2022

Researchers developed polygenic risk scores for 6 common diseases and informational resources to help primary care physicians incorporate them into clinical practice.

FDA Accepts Daprodustat NDA for Anemia of Chronic Kidney Disease
April 20, 2022

The NDA for daprodustat, a novel investigational agent, is based on data from pivotal ASCEND program clinical trials.

Expanding Reach Beyond Clinic Walls is Essential to the Future of Health Care, says Investigator
April 15, 2022

SuperWIN trial findings suggest the future of successful health care depends on harnessing familiar, community- based resources to maintain health and deliver care.

Finerenone Consistently Reduced Cardiorenal Risk Regardless of ASCVD History in FIDELITY
April 08, 2022

In patients with type 2 diabetes and chronic kidney disease with and without history of CVD, finerenone was associated with improved CV and kidney outcomes.